Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors

Hepatology Research

Volumn 46, Issue 10, 2016, Pages 977-984

  Akazawa, Yuko ^a   Nakao, Kazuhiko ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

apoptosis; BH3 interacting domain death agonist protein; cell derived microparticles; endoplasmic reticulum stress; free fatty acids; non alcoholic steatohepatitis

Indexed keywords

DEATH RECEPTOR; MICRORNA; PROTEIN BCL 2; PROTEIN IRE1; STRESS ACTIVATED PROTEIN KINASE 1; X BOX BINDING PROTEIN 1;

APOPTOSIS; CAUSAL ATTRIBUTION; CELL ACTIVITY; CELL DEATH; CELL FATE; CELL INTERACTION; CELL SURVIVAL; CELL TRANSPORT; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HUMAN; LIPOTOXICITY; LIVER CELL; MEMBRANE MICROPARTICLE; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84985945504     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12658     Document Type: Review

References (68)

1. Watanabe S, Hashimoto E, Ikejima K et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatol Res 2015; 45: 363–77.
2. Feldstein AE, Canbay A, Angulo P et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003; 125: 437–43.
3. Puri P, Baillie RA, Wiest MM et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007; 46: 1081–90.
4. Donnelly KL, Smith CI, Schwarzenberg SJ et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1343–51.
5. Akazawa Y, Cazanave S, Mott JL et al. Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. J Hepatol 2010; 52: 586–93.
6. Kakisaka K, Cazanave SC, Werneburg NW et al. A hedgehog survival pathway in ‘undead’ lipotoxic hepatocytes. J Hepatol 2012; 57: 844–51.
7. Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999; 397: 271–4.
8. Cox JS, Shamu CE, Walter P. Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase. Cell 1993; 73: 1197–206.
9. Shuda M, Kondoh N, Imazeki N et al. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 2003; 38: 605–14.
10. Lake AD, Novak P, Hardwick RN et al. The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease. Toxicol Sci 2014; 137: 26–35.
11. Cazanave SC, Elmi NA, Akazawa Y et al. CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis. Am J Physiol Gastrointest Liver Physiol 2010; 299: G236–43.
12. Zinszner H, Kuroda M, Wang X et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 1998; 12: 982–95.
13. Cazanave SC, Mott JL, Bronk SF et al. Death receptor 5 signaling promotes hepatocyte lipoapoptosis. J Biol Chem 2011; 286: 39336–48.
14. Cao J, Dai DL, Yao L et al. Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathway. Mol Cell Biochem 2012; 364: 115–29.
15. Rinella ME, Siddiqui MS, Gardikiotes K et al. Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis. Hepatology 2011; 54: 1600–9.
16. Lebeaupin C, Proics E, de Bieville CH et al. ER stress induces NLRP3 inflammasome activation and hepatocyte death. Cell Death Dis 2015; 6: e1879.
17. Malhi H, Kropp EM, Clavo VF et al. C/EBP homologous protein-induced macrophage apoptosis protects mice from steatohepatitis. J Biol Chem 2013; 288: 18624–42.
18. Han D, Lerner AG, Vande Walle L et al. IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell 2009; 138: 562–75.
19. Liu X, Henkel AS, LeCuyer BE et al. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high fat/sugar diet. Am J Physiol Gastrointest Liver Physiol 2015; 309: G965–74.
20. Olivares S, Henkel AS. Hepatic Xbp1 deletion promotes endoplasmic reticulum stress-induced liver injury and apoptosis. J Biol Chem 2015; 290: 30142–51.
21. Ye D, Li FY, Lam KS et al. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice. Gut 2012; 61: 1058–67.
22. Ning J, Hong T, Ward A et al. Constitutive role for IRE1alpha-XBP1 signaling pathway in the insulin-mediated hepatic lipogenic program. Endocrinology 2011; 152: 2247–55.
23. Lee AH, Scapa EF, Cohen DE et al. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 2008; 320: 1492–6.
24. Glimcher LH, Lee AH. From sugar to fat: how the transcription factor XBP1 regulates hepatic lipogenesis. Ann NY Acad Sci 2009; 1173(Suppl 1): E2–9.
25. Dara L, Ji C, Kaplowitz N. The contribution of endoplasmic reticulum stress to liver diseases. Hepatology 2011; 53: 1752–63.
26. Shimizu Y, Hendershot LM. Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species. Antioxid Redox Signal 2009; 11: 2317–31.
27. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006; 43: S31–44.
28. Cazanave SC, Mott JL, Elmi NA et al. JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J Biol Chem 2009; 284: 26591–602.
29. Malhi H, Bronk SF, Werneburg NW et al. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 2006; 281: 12093–101.
30. Czaja MJ. Cell signaling in oxidative stress-induced liver injury. Semin Liver Dis 2007; 27: 378–89.
31. Schattenberg JM, Singh R, Wang Y et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 2006; 43: 163–72.
32. Malhi H, Barreyro FJ, Isomoto H et al. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut 2007; 56: 1124–31.
33. Sharma M, Urano F, Jaeschke A. Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes. J Hepatol 2012; 56: 192–8.
34. Ibrahim SH, Akazawa Y, Cazanave SC et al. Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis. J Hepatol 2011; 54: 765–72.
35. Ibrahim SH, Gores GJ, Hirsova P et al. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis. Liver Int 2014; 34: 427–37.
36. Cazanave SC, Wang X, Zhou H et al. Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis. Cell Death Differ 2013; 21: 1303–12.
37. Hatting M, Zhao G, Schumacher F et al. Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents. Hepatology 2013; 57: 2189–201.
38. Akazawa Y, Guicciardi ME, Cazanave SC et al. Degradation of cIAPs contributes to hepatocyte lipoapoptosis. Am J Physiol Gastrointest Liver Physiol 2013; 305: G611–9.
39. Reinehr R, Sommerfeld A, Haussinger D. Insulin induces swelling-dependent activation of the epidermal growth factor receptor in rat liver. J Biol Chem 2010; 285: 25904–12.
40. Crespo J, Cayon A, Fernandez-Gil P et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001; 34: 1158–63.
41. Ribeiro PS, Cortez-Pinto H, Sola S et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 2004; 99: 1708–17.
42. Feldstein AE, Werneburg NW, Canbay A et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004; 40: 185–94.
43. Li Z, Yang S, Lin H et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003; 37: 343–50.
44. Koca SS, Bahcecioglu IH, Poyrazoglu OK et al. The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Inflammation 2008; 31: 91–8.
45. Hirsova P, Gores GJ. Death receptor-mediated cell death and proinflammatory signaling in nonalcoholic steatohepatitis. Cell Mol Gastroenterol Hepatol 2015; 1: 17–27.
46. Idrissova L, Malhi H, Werneburg NW et al. TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess. J Hepatol 2015; 62: 1156–63.
47. Mukai K, Miyagi T, Nishio K et al. S100A8 production in CXCR2-expressing CD11b + Gr-1high cells aggravates hepatitis in mice fed a high-fat and high-cholesterol diet. J Immunol 2016; 196: 395–406.
48. vCazanave SC, Gores GJ. The liver's dance with death: two Bcl-2 guardian proteins from the abyss. Hepatology 2009; 50: 1009–13.
49. Tzung SP, Fausto N, Hockenbery DM. Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol 1997; 150: 1985–95.
50. Feldstein AE, Werneburg NW, Li Z et al. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1339–46.
51. Barreyro FJ, Kobayashi S, Bronk SF et al. Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. J Biol Chem 2007; 282: 27141–54.
52. Eguchi A, De Mollerat Du Jeu X, Johnson CD et al. Liver Bid-suppression for treatment of fibrosis associated with nonalcoholic steatohepatitis. J Hepatol 2015.
53. Masuoka HC, Mott J, Bronk SF et al. Mcl-1 degradation during hepatocyte lipoapoptosis. J Biol Chem 2009; 284: 30039–48.
54. Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis 2011; 35: 3–11.
55. Davalos A, Goedeke L, Smibert P et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci USA 2011; 108: 9232–7.
56. Pogribny IP, Starlard-Davenport A, Tryndyak VP et al. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest 2010; 90: 1437–46.
57. Bartoszewski R, Brewer JW, Rab A et al. The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes. J Biol Chem 2011; 286: 41862–70.
58. Upton JP, Wang L, Han D et al. IRE1alpha cleaves select microRNAs during ER stress to derepress translation of proapoptotic caspase-2. Science 2012; 338: 818–22.
59. Miyamoto Y, Mauer AS, Kumar S et al. Mmu-miR-615-3p regulates lipoapoptosis by inhibiting C/EBP homologous protein. PLoS One 2014; 9: e109637.
60. Cazanave SC, Mott JL, Elmi NA et al. A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA. J Lipid Res 2011; 52: 1517–25.
61. Esau C, Davis S, Murray SF et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3: 87–98.
62. Miyaaki H, Ichikawa T, Kamo Y et al. Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease. Liver Int 2014; 34: e302–7.
63. Povero D, Eguchi A, Niesman IR et al. Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require vanin-1 for uptake by endothelial cells. Sci Signal 2013; 6: ra88.
64. Kakazu E, Mauer AS, Yin M et al. Hepatocytes release ceramide-enriched proinflammatory extracellular vesicles in an IRE1α-dependent manner. J Lipid Res 2016; 57: 233–45.
65. Ibrahim SH, Hirsova P, Tomita K et al. Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. Hepatology 2016; 63: 731–44
66. Coulon S, Legry V, Heindryckx F et al. Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models. Hepatology 2013; 57: 1793–805.
67. Povero D, Eguchi A, Li H et al. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One 2014; 9: e113651.
68. Machado MV, Michelotti GA, Pereira Tde A et al. Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. Gut 2011; 64: 1148–57.